Novartis Ag ADR
(NVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVS | ABBV | MRK | ||
| Company | Novartis Ag ADR | Abbvie Inc | Merck & Company | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 152.00 | 216.90 | 118.31 | ||
| High | 154.95 | 219.87 | 122.43 | ||
| Low | 151.68 | 214.04 | 118.31 | ||
| Latest | 153.95 | 219.02 | 119.75 | ||
| Change | +1.04 | +1.91 | +1.42 | ||
| % Change | +0.68% | +0.88% | +1.20% | ||
| Volume | 4,100,200 | 10,794,000 | 24,010,500 | ||
| 20-Day Average Volume | 2,066,135 | 7,681,645 | 14,277,670 | ||
| Previous Close | 152.91 | 217.11 | 118.33 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 146.77 | 219.99 | 110.79 | ||
| 20-Day Raw Stochastic | 93.17% | 54.09% | 83.66% | ||
| 20-Day Relative Strength | 69.27 | 46.63 | 72.46 | ||
| Weighted Alpha | +50.06 | +13.81 | +52.47 | ||
| Today's Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 48% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.38% since 01/29/26 | -0.64% since 01/29/26 | +10.53% since 01/29/26 | ||
| Low | 148.13 on 01/30/26 | 204.27 on 02/04/26 | 107.95 on 01/30/26 | ||
| High | 154.95 on 02/05/26 | 229.79 on 02/02/26 | 122.43 on 02/05/26 | ||
| 1-Month | |||||
| %Chg | +11.63% since 01/05/26 | -0.53% since 01/05/26 | +11.46% since 01/05/26 | ||
| Low | 139.09 on 01/06/26 | 204.27 on 02/04/26 | 106.03 on 01/28/26 | ||
| High | 154.95 on 02/05/26 | 237.04 on 01/07/26 | 122.43 on 02/05/26 | ||
| 3-Month | |||||
| %Chg | +22.67% since 11/05/25 | +1.04% since 11/05/25 | +41.90% since 11/05/25 | ||
| Low | 123.24 on 11/20/25 | 204.27 on 02/04/26 | 84.35 on 11/06/25 | ||
| High | 154.95 on 02/05/26 | 239.29 on 11/13/25 | 122.43 on 02/05/26 | ||
| 6-Month | |||||
| %Chg | +30.77% since 08/05/25 | +10.31% since 08/05/25 | +48.22% since 08/05/25 | ||
| Low | 113.48 on 08/06/25 | 194.67 on 08/06/25 | 77.58 on 09/25/25 | ||
| High | 154.95 on 02/05/26 | 244.81 on 10/01/25 | 122.43 on 02/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 323,010,496 | 383,716,960 | 293,697,792 | ||
| Shares Outstanding, K | 2,112,422 | 1,767,385 | 2,482,023 | ||
| Annual Sales | 51,722,000,000 | 56,334,000,000 | 64,168,000,000 | ||
| Annual Net Income | 11,941,000,000 | 4,278,000,000 | 17,117,000,000 | ||
| Last Quarter Sales | 14,358,000,000 | 15,776,000,000 | 17,276,000,000 | ||
| Last Quarter Net Income | 3,928,000,000 | 186,000,000 | 5,785,000,000 | ||
| 60-Month Beta | 0.50 | 0.35 | 0.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.03 on 02/04/26 | 2.71 on 02/04/26 | 2.04 on 02/03/26 | ||
| Latest Earnings Date | 02/04/26 | 02/04/26 | 04/23/26 | ||
| Most Recent Dividend | 2.596 on 03/12/25 | 1.730 on 01/16/26 | 0.850 on 12/15/25 | ||
| Next Ex-Dividends Date | 03/12/25 | 01/16/26 | 03/16/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 16.78 | 23.88 | 12.91 | ||